Andreas W. Herling

Sanofi R&D
Frankfurt Am Main, HE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A).

CB1 Receptor-Dependent and Independent Induction of Lipolysis in Primary Rat Adipocytes by the Inverse Agonist Rimonabant (SR141716A).

Journal: Molecules (Basel, Switzerland)

Published: December 17, 2019

Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.

Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.

Journal: Biochemistry. Biokhimiia

Published: September 17, 2019

Chip-based sensing for release of unprocessed cell surface proteins in vitro and in serum and its (patho)physiological relevance.

Chip-based sensing for release of unprocessed cell surface proteins in vitro and in serum and its (patho)physiological relevance.

Journal: American journal of physiology. Endocrinology and metabolism

Published: May 01, 2019

Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations.

Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists Specifically Optimized for Multidose Formulations.

Journal: Journal of medicinal chemistry

Published: June 08, 2018

Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys.

Team Players or Opponents: Coadministration of Selective Glucagon and GLP-1 Receptor Agonists in Obese Diabetic Monkeys.

Journal: Endocrinology

Published: April 26, 2018

A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone.

A metabolome-wide characterization of the diabetic phenotype in ZDF rats and its reversal by pioglitazone.

Journal: PloS one

Published: April 20, 2018

Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.

Running on mixed fuel-dual agonistic approach of GLP-1 and GCG receptors leads to beneficial impact on body weight and blood glucose control: A comparative study between mice and non-human primates.

Journal: Diabetes, obesity & metabolism

Published: May 09, 2017

The role of insulin resistance in experimental diabetic retinopathy-Genetic and molecular aspects.

The role of insulin resistance in experimental diabetic retinopathy-Genetic and molecular aspects.

Journal: PloS one

Published: January 26, 2017

Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.

Characterization of RA839, a Noncovalent Small Molecule Binder to Keap1 and Selective Activator of Nrf2 Signaling.

Journal: The Journal of biological chemistry

Published: July 10, 2015

Expression patterning reveals retinal inflammation as a minor factor in experimental retinopathy of ZDF rats.

Expression patterning reveals retinal inflammation as a minor factor in experimental retinopathy of ZDF rats.

Journal: Acta diabetologica

Published: August 21, 2013

Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.

Benzimidazole-carboxamides as potent and bioavailable stearoyl-CoA desaturase (SCD1) inhibitors from ligand-based virtual screening and chemical optimization.

Journal: Bioorganic & medicinal chemistry letters

Published: November 19, 2012

Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).

Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).

Journal: European journal of pharmacology

Published: September 10, 2012

Showing 1-12 of 16

Last Updated: 09/26/2026